Status:
COMPLETED
Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation
Lead Sponsor:
California Pacific Medical Center Research Institute
Collaborating Sponsors:
San Francisco General Hospital
University of California, San Francisco
Conditions:
Nasal Congestion
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA)....
Detailed Description
Subjects will screen at St. Luke's Hospital in San Francisco to determine their eligibility. Once enrolled the study will take two weeks. During the first week subjects attend daily, hour-long outpat...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy Males and Females Between the Ages of 18 and 50
- Must have some experience with methamphetamine
Exclusion
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00829634
Start Date
October 1 2008
End Date
September 1 2009
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CPMC Addiction & Pharmacology Research Laboratory (APRL)
San Francisco, California, United States, 94110